Aulisa Medical USA, Inc.

Aulisa Medical is a Palo Alto, CA-based medical device company founded in 2012 that develops FDA-cleared, wireless wearable patient monitoring systems for continuous vital sign tracking in clinical and home environments. The company specializes in cloud-based remote monitoring solutions utilizing artificial intelligence to detect inconsistencies in vital sign data and enable early intervention for potentially adverse events. Products are designed for infants, children, and adults across multiple care settings. The Guardian Angel® product line serves as the primary offering, functioning as both a consumer baby monitor and clinical-grade vital sign monitoring device. Applications include monitoring for sleep safety, chronic respiratory diseases (COPD, sleep apnea), cardiac conditions, post-procedure recovery, and aging-in-place scenarios. The company addresses the need to reduce manual vital sign spot-checking burden for both clinicians and caregivers through automated, continuous monitoring with alert capabilities. Aulisa has achieved FDA clearance for its devices and is backed by Silicon Valley venture capital investors. The company operates both direct-to-consumer and hospital/clinical distribution channels, with products available for in-home use and institutional hospital settings.